DRUG
Contact Ed Stannard at edward.stannard@hearstmediact.com or 203-680-9382.
KICKOFF
Wagner had been misdiagnosed with Duchenne muscular dystrophy and so was able to be enrolled in PTC’s trial for ataluren, which is targeted for Duchenne. He was allowed to continue in the trial once he was diagnosed with Becker.
“My muscles, when I...
Read latest New Haven Register (New Haven, CT) online.
Online newspapers
at PressDisplay.